Summary & Overview
CPT 93701: Cardiac Bioimpedance Study
CPT code 93701 represents a bioimpedance study used to assess cardiovascular physiology by measuring thoracic impedance and deriving parameters related to heart function and fluid status. Nationally, this diagnostic test is relevant for cardiology services that evaluate heart performance, manage heart failure, and monitor fluid balance. The code is used across outpatient diagnostic centers and hospital cardiology labs and factors into utilization, billing workflows, and coverage determinations.
Key payers included in the analysis are Aetna, Blue Cross Blue Shield, Cigna Health, UnitedHealthcare, and Medicare. Readers will find an overview of clinical context for the procedure, typical sites of service, and what to expect in payer coverage considerations. The publication summarizes benchmarks for utilization and reimbursement, highlights policy updates affecting diagnostic cardiovascular testing, and outlines clinical scenarios in which a bioimpedance study may be documented. The content is intended for billing professionals, clinical administrators, and policy analysts seeking concise guidance on coding, billing, and the role of this diagnostic test in care pathways.
Data not available in the input: associated taxonomies, specific ICD-10 diagnoses, related codes, and detailed payer-specific coverage rules.
Billing Code Overview
CPT code 93701 describes a bioimpedance study of cardiovascular function. The procedure measures thoracic bioimpedance to estimate physiological cardiac parameters that aid evaluation of cardiovascular status and fluid dynamics.
Service Type: Diagnostic cardiovascular testing
Typical Site of Service: Outpatient diagnostic facility or hospital-based cardiology lab
Clinical & Coding Specifications
Clinical Context
A 64-year-old male with a history of hypertension and chronic ischemic cardiomyopathy presents to an outpatient cardiology clinic for evaluation of progressive exertional dyspnea and lower extremity edema. The cardiologist orders a transthoracic echocardiogram and an adjunctive noninvasive hemodynamic assessment using bioimpedance cardiography to quantify cardiac output, stroke volume, systemic vascular resistance, and thoracic fluid content. The patient is placed supine on an examination table; surface electrodes are applied to the neck and thorax, and the bioimpedance study is performed at rest and during a short orthostatic challenge. Results are reviewed by the interpreting physician: measured low cardiac output and elevated thoracic fluid content guide medication adjustment and planning for closer outpatient follow-up. Typical site of service is an outpatient cardiology clinic or hospital-based cardiology diagnostic lab. Service type is noninvasive cardiovascular diagnostic testing performed and interpreted by a qualified clinician.
Coding Specifications
| Modifier | Description | When to Use |
|---|---|---|
26 | Professional component | Use when reporting only the physician interpretation of the bioimpedance study separate from technical performance |
TC |